Skip to content
Skip to library content

Category 16

Recognizing Misleading Claims and Unproven Treatments

9 topics planned. Each topic is published as a Professional and Patient edition only after explicit author approval.

  • 16.1Common misleading phrases
    In preparation
    1. · “FDA registered”
    2. · “FDA compliant”
    3. · “Clinical grade”
    4. · “No rejection”
    5. · “Immune privileged”
    6. · “Zero risk”
    7. · “Guaranteed”
    8. · “Repairs any tissue”
  • 16.2Misuse of scientific evidence
    In preparation
    1. · Animal studies presented as human proof
    2. · One product used to support another
    3. · Case reports presented as trials
    4. · Abstract-only citations
    5. · Selective outcome reporting
    6. · Testimonials replacing data
  • 16.3Misrepresentation of regulation
    In preparation
    1. · Registration versus approval
    2. · IND versus approval
    3. · IRB review versus efficacy
    4. · ClinicalTrials.gov listing versus endorsement
    5. · Laboratory certification versus product authorization
  • 16.4Product ambiguity
    In preparation
    1. · Unspecified cell source
    2. · Undefined cell count
    3. · No viability data
    4. · No potency data
    5. · No certificate of analysis
    6. · No manufacturer identification
    7. · No batch number
  • 16.5Exosome-specific red flags
    In preparation
    1. · Particle count without purity
    2. · No EV characterization
    3. · Unverified cargo claims
    4. · “Billions of exosomes”
    5. · No sterility or endotoxin testing
    6. · Topical product promoted for systemic disease
  • 16.6Clinic red flags
    In preparation
    1. · One product for unrelated diseases
    2. · Sales pressure
    3. · Same-day treatment
    4. · Large upfront payment
    5. · Financing incentives
    6. · No emergency plan
    7. · No long-term follow-up
  • 16.7Marketing methods
    In preparation
    1. · Celebrity endorsements
    2. · Influencer testimonials
    3. · Before-and-after photographs
    4. · Emotional patient stories
    5. · Fear of conventional medicine
    6. · Claims of regulatory conspiracy
  • 16.8Financial warning signs
    In preparation
    1. · Treatment bundles
    2. · Pay-to-participate trials
    3. · Nonrefundable deposits
    4. · Cash-only policies
    5. · Hidden follow-up costs
    6. · Charges for complications
  • 16.9How to investigate a claim
    In preparation
    1. · Identify the exact product
    2. · Locate the original study
    3. · Verify the study population
    4. · Verify regulatory status
    5. · Review adverse events
    6. · Obtain an independent specialist opinion